Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Virtual Route d: A Survey of \Exploring On the web Stages\ Web Administration - 2Electric Vehicles for Eco-Accommodating Driving
- 3WHO suspends Gaza medical evacuations after contractor killed by Israeli troops
- 4Moon memorial: Artemis 2 astronauts name lunar 'bright spot' after mission commander's late wife
- 5Poll: 62% of Americans would oppose U.S. military action in Greenland
- ‘Extraordinary’ Iron Age war trumpet uncovered in England
- Banks for High Fixed Store Rates: Amplify Your Reserve funds
- How to watch 'A Charlie Brown Christmas' for free this weekend
- Step into Nature: A Survey of \Handling Trails with Solace\ Climbing Shoes
- Israel says Iran's military industry will be destroyed 'within days'
- James Webb Space Telescope watches 'Jekyll and Hyde' galaxy shapeshift into a cosmic monster
- Fundamental Monetary Guidance for Going into Business
- Artemis will take Americans to the moon for the 1st time since 1972. Why has it been so hard to go back?
- Former elite Australian soldier charged with Afghan war crimes
